Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Cost-effectiveness analysis of initial treatment strategies for mild-to-moderate Clostridium difficile infection in hospitalized patients.

Ford DC, Schroeder MC, Ince D, Ernst EJ.

Am J Health Syst Pharm. 2018 Aug 1;75(15):1110-1121. doi: 10.2146/ajhp170554. Epub 2018 Jun 14.

PMID:
29903711
2.

Implementation of a Mobile Clinical Decision Support Application to Augment Local Antimicrobial Stewardship.

Hoff BM, Ford DC, Ince D, Ernst EJ, Livorsi DJ, Heintz BH, Masse V, Brownlee MJ, Ford BA.

J Pathol Inform. 2018 Apr 2;9:10. doi: 10.4103/jpi.jpi_77_17. eCollection 2018.

3.

Incidence of Serotonin Syndrome With Combined Use of Linezolid and Serotonin Reuptake Inhibitors Compared With Linezolid Monotherapy.

Karkow DC, Kauer JF, Ernst EJ.

J Clin Psychopharmacol. 2017 Oct;37(5):518-523. doi: 10.1097/JCP.0000000000000751.

PMID:
28796019
4.

Antimicrobial utilization in an Iraqi province: a comprehensive evaluation of antibiotic source and cost.

Al-Jumaili AA, Hussein AH, Al-Rekabi MD, Raheem SA, Ernst EJ.

Int J Pharm Pract. 2017 Feb;25(1):81-88. doi: 10.1111/ijpp.12338.

PMID:
28097722
5.

Development of a medication monitoring attitude measure using a mixed methods item development process.

Witry MJ, Wesely PM, Goedken AM, Ernst EJ, Sorofman BA, Doucette WR.

Int J Pharm Pract. 2016 Feb;24(1):49-59. doi: 10.1111/ijpp.12185. Epub 2015 Mar 10.

PMID:
25756349
6.

Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobials.

Justo JA, Gauthier TP, Scheetz MH, Chahine EB, Bookstaver PB, Gallagher JC, Hermsen ED, DePestel DD, Ernst EJ, Jacobs DM, Esterly JS, Suda KJ, Olsen KM, Abbo LM, MacDougall C.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S162-9. doi: 10.1093/cid/ciu537.

7.

Factors that influence the variability in findings of anogenital injury in adolescent/adult sexual assault victims: a review of the forensic literature.

Laitinen FA, Grundmann O, Ernst EJ.

Am J Forensic Med Pathol. 2013 Sep;34(3):286-94. doi: 10.1097/PAF.0b013e31829a0f46. Review.

PMID:
23835534
8.

Analysis of possible sexual assault or abuse in a 67-year-old female with early dementia post-brain attack.

Speck PM, Kennedy BL, Henry ND, Ernst EJ.

Adv Emerg Nurs J. 2013 Jul-Sep;35(3):217-39. doi: 10.1097/TME.0b013e31827ef655.

PMID:
23797614
9.

The element of naturalness when evaluating image quality of digital photo documentation after sexual assault.

Ernst EJ, Speck PM, Fitzpatrick JJ.

Adv Emerg Nurs J. 2012 Jul-Sep;34(3):250-8. doi: 10.1097/TME.0b013e3182616eb2.

PMID:
22842968
10.

Systemic exposure to aminoglycosides following knee and hip arthroplasty with aminoglycoside-loaded bone cement implants.

Kalil GZ, Ernst EJ, Johnson SJ, Johannsson B, Polgreen PM, Bertolatus JA, Clark CR.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):929-34. doi: 10.1345/aph.1R049. Epub 2012 Jul 3.

PMID:
22764326
11.

Antimicrobial therapy for bloodstream infection due to methicillin-susceptible Staphylococcus aureus in an era of increasing methicillin resistance: opportunities for antimicrobial stewardship.

Johannsson B, Johnson SJ, Ernst EJ, Beekmann SE, Herwaldt L, Diekema DJ, Polgreen PM.

Ann Pharmacother. 2012 Jun;46(6):904-5. doi: 10.1345/aph.1Q406. Epub 2012 Jun 5. No abstract available.

PMID:
22669794
12.

Correlates of Adherence among Rural Indian Women Living with HIV/AIDS.

Nyamathi A, Salem B, Ernst EJ, Keenan C, Suresh P, Sinha S, Ganguly K, Ramakrishnan P, Liu Y.

J HIV AIDS Soc Serv. 2012;11(4):327-345.

13.

Evaluation of image quality of digital photo documentation of female genital injuries following sexual assault.

Ernst EJ, Speck PM, Fitzpatrick JJ.

J Forensic Nurs. 2011 Dec;7(4):182-9. doi: 10.1111/j.1939-3938.2011.01103.x.

PMID:
22123038
14.

Usefulness: forensic photo documentation after sexual assault.

Ernst EJ, Speck PM, Fitzpatrick JJ.

Adv Emerg Nurs J. 2011 Jan-Mar;33(1):29-38. doi: 10.1097/TME.0b013e3182083128.

PMID:
21317696
15.

Is double coverage of gram-negative organisms necessary?

Johnson SJ, Ernst EJ, Moores KG.

Am J Health Syst Pharm. 2011 Jan 15;68(2):119-24. doi: 10.2146/ajhp090360.

PMID:
21200057
16.

The new American Academy of Orthopedic Surgeons' recommendations regarding antibiotic prophylaxis: where's the evidence?

Marek CL, Ernst EJ.

Spec Care Dentist. 2009 Nov-Dec;29(6):229-31. doi: 10.1111/j.1754-4505.2009.00109.x. No abstract available.

PMID:
19886933
17.

Recommendations for training and certification for pharmacists practicing, mentoring, and educating in infectious diseases pharmacotherapy.

Ernst EJ, Klepser ME, Bosso JA, Rybak MJ, Hermsen ED, Segarra-Newnham M, Drew RH.

Pharmacotherapy. 2009 Apr;29(4):482-8. doi: 10.1592/phco.29.4.482.

PMID:
19323625
18.

Atmospheric pressure changes and unexplained variability in INR measurements.

Ernst ME, Shaw RF, Ernst EJ, Alexander B, Kaboli PJ.

Blood Coagul Fibrinolysis. 2009 Jun;20(4):263-70. doi: 10.1097/MBC.0b013e3283257ffc.

PMID:
19300239
19.

Do antibiotics affect the quality of life of patients with upper respiratory tract illnesses? It might depend on one's luck.

Bergus GR, Weber CA, Ernst ME, Ernst EJ.

Int J Clin Pract. 2008 Jun;62(6):855-9. doi: 10.1111/j.1742-1241.2008.01775.x.

PMID:
18479279
20.

Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.

Klevay MJ, Ernst EJ, Hollanbaugh JL, Miller JG, Pfaller MA, Diekema DJ.

Diagn Microbiol Infect Dis. 2008 Mar;60(3):273-7. Epub 2007 Nov 19.

PMID:
18024053
21.

Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals.

Zillich AJ, Sutherland JM, Wilson SJ, Diekema DJ, Ernst EJ, Vaughn TE, Doebbeling BN.

Infect Control Hosp Epidemiol. 2006 Oct;27(10):1088-95. Epub 2006 Sep 18.

PMID:
17006817
22.

Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteremia.

Ernst EJ, Raley G, Herwaldt LA, Diekema DJ.

Infect Control Hosp Epidemiol. 2005 Jul;26(7):634-7.

PMID:
16092744
23.

Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment.

Ernst EJ, Ernst ME, Hoehns JD, Bergus GR.

Health Qual Life Outcomes. 2005 Jul 27;3:45.

24.

Susceptibility testing methods of antifungal agents.

Ernst EJ.

Methods Mol Med. 2005;118:3-12.

PMID:
15888930
25.

Variation in the use of procedures to monitor antimicrobial resistance in U.S. hospitals.

Flach SD, Diekema DJ, Yankey JW, BootsMiller BJ, Vaughn TE, Ernst EJ, Ward MM, Doebbeling BN.

Infect Control Hosp Epidemiol. 2005 Jan;26(1):31-8.

PMID:
15693406
26.

Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?

Ernst EJ, Diekema DJ, BootsMiller BJ, Vaughn T, Yankey JW, Flach SD, Ward MM, Franciscus CL, Acosta E, Pfaller MA, Doebbeling BN.

Diagn Microbiol Infect Dis. 2004 Jun;49(2):141-5.

PMID:
15183864
27.
28.

Antimicrobial resistance trends and outbreak frequency in United States hospitals.

Diekema DJ, BootsMiller BJ, Vaughn TE, Woolson RF, Yankey JW, Ernst EJ, Flach SD, Ward MM, Franciscus CL, Pfaller MA, Doebbeling BN.

Clin Infect Dis. 2004 Jan 1;38(1):78-85. Epub 2003 Dec 8.

PMID:
14679451
29.

Health care resource utilization associated with treatment of penicillin-susceptible and -nonsusceptible isolates of Streptococcus pneumoniae.

Klepser ME, Klepser DG, Ernst EJ, Brooks J, Diekema DJ, Mozaffari E, Hendrickson J, Doern GV.

Pharmacotherapy. 2003 Mar;23(3):349-59.

PMID:
12627934
30.

Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model.

Hoffman HL, Klepser ME, Ernst EJ, Petzold CR, Sa'adah LM, Doern GV.

Antimicrob Agents Chemother. 2003 Feb;47(2):739-46.

31.

In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies.

Ernst EJ, Roling EE, Petzold CR, Keele DJ, Klepser ME.

Antimicrob Agents Chemother. 2002 Dec;46(12):3846-53.

32.
33.

Celecoxib-induced erythema multiforme with glyburide cross-reactivity.

Ernst EJ, Egge JA.

Pharmacotherapy. 2002 May;22(5):637-40.

PMID:
12013363
34.
36.

Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.

Keele DJ, DeLallo VC, Lewis RE, Ernst EJ, Klepser ME.

Diagn Microbiol Infect Dis. 2001 Nov;41(3):121-6.

PMID:
11750164
37.

Investigational antifungal agents.

Ernst EJ.

Pharmacotherapy. 2001 Aug;21(8 Pt 2):165S-174S. Review.

PMID:
11501989
39.

Novel triazole antifungal agents.

Hoffman HL, Ernst EJ, Klepser ME.

Expert Opin Investig Drugs. 2000 Mar;9(3):593-605. Review.

PMID:
11060698
40.

In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect.

Gunderson SM, Hoffman H, Ernst EJ, Pfaller MA, Klepser ME.

Antimicrob Agents Chemother. 2000 Oct;44(10):2887-90.

41.

Evaluation of voriconazole pharmacodynamics using time-kill methodology.

Klepser ME, Malone D, Lewis RE, Ernst EJ, Pfaller MA.

Antimicrob Agents Chemother. 2000 Jul;44(7):1917-20.

42.

Comparison of the serum and intracellular pharmacokinetics of azithromycin in healthy and diabetic volunteers.

Ernst EJ, Klepser ME, Klepser TB, Nightingale CH, Hunsicker LG.

Pharmacotherapy. 2000 Jun;20(6):657-61.

PMID:
10853621
43.
44.
45.

Effectively treating common infections in residents of long-term care facilities.

Ernst ME, Ernst EJ.

Pharmacotherapy. 1999 Sep;19(9):1026-35. Review.

PMID:
10610008
46.

Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model.

Ernst EJ, Hashimoto S, Guglielmo J, Sawa T, Pittet JF, Kropp H, Jackson JJ, Wiener-Kronish JP.

Antimicrob Agents Chemother. 1999 Oct;43(10):2389-94.

47.

Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection.

Lewis RE, Klepser ME, Ernst EJ, Lund BC, Biedenbach DJ, Jones RN.

Antimicrob Agents Chemother. 1999 Aug;43(8):2005-9.

48.

In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods.

Ernst EJ, Klepser ME, Ernst ME, Messer SA, Pfaller MA.

Diagn Microbiol Infect Dis. 1999 Feb;33(2):75-80.

PMID:
10091029
49.
50.

Strategies in the treatment of penicillin-resistant Streptococcus pneumoniae.

Lund BC, Ernst EJ, Klepser ME.

Am J Health Syst Pharm. 1998 Oct 1;55(19):1987-94. Review.

PMID:
9784785

Supplemental Content

Loading ...
Support Center